Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Collaboration › Details

Orchard Therapeutics–LifeSci: public relations, 201712 service existent by LifeSci Public Relations


Period Period 2017-12-22
Organisations Partner, 1st Orchard Therapeutics Ltd.
  Group Orchard Therapeutics (Group)
  Partner, 2nd LifeSci Public Relations LLC
  Group LifeSci (Group)
Products Product public relations / investor relations / marcom (services)
  Product 2 gene therapy
Person Person Blum, Allison (LifeSci Public Relations 201712)

Orchard Therapeutics Ltd.. (12/22/17). "Press Release: Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference". London.

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced that Mark Rothera, president and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 9, 2018 at 3:00 p.m. PT.

About Orchard Therapeutics

Orchard Therapeutics is a privately-held clinical-stage biotechnology company based in the UK and in California, US. Orchard is dedicated to transforming the lives of patients with rare disorders through innovative gene therapies. Orchard works in partnership with some of the world's leading centres in gene therapy, including University College London, Great Ormond Street Hospital for Children NHS Foundation Trust, the University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, the University of California Los Angeles and Boston Children’s Hospital. In 2016 the company was named a Fierce 15 Company by Fierce Biotech. Also, Orchard and UCLA were awarded a $19 million grant from the California Institute of Regenerative Medicine (CIRM) in 2016 to advance the development of autologous ex-vivo lentiviral gene therapy in ADA-SCID.


Corporate contact
Nicolas Koebel
+44 (0) 7717 801246

Media contact
Allison Blum, Ph.D.
LifeSci Public Relations
+1 516 655 0842

Record changed: 2020-04-22


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Orchard Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px

» top